Summary
In a significant market movement during February 2023, Syndi Health was the subject of a vc funding. The transaction achieved a gross valuation of £1,650,000. Leading the round was Stephen Bourke, David Giampaolo, Roland Rudd, Jacob Haddad, Founders Factory, Phil Mohr, Neo Kuma Ventures, Baron O'Shaughnessy, Syndicate Room's Access Fund, Remus Capital, Damien Marmion, Puli Liyanagama, Plug and Play.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Stephen Bourke
Lead Investor / Acquirer
David Giampaolo
Lead Investor / Acquirer
Roland Rudd
Lead Investor / Acquirer
Jacob Haddad
Lead Investor / Acquirer
Founders Factory
Lead Investor / Acquirer
Phil Mohr
Lead Investor / Acquirer
Neo Kuma Ventures
Lead Investor / Acquirer
Baron O'Shaughnessy
Lead Investor / Acquirer
Syndicate Room's Access Fund
Lead Investor / Acquirer
Remus Capital
Lead Investor / Acquirer
Damien Marmion
Lead Investor / Acquirer
Puli Liyanagama
Lead Investor / Acquirer
Plug
Lead Investor / Acquirer
Play
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Pre-Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in